COMBINATORIAL THERAPY
    50.
    发明申请
    COMBINATORIAL THERAPY 审中-公开
    组合治疗

    公开(公告)号:US20140004038A1

    公开(公告)日:2014-01-02

    申请号:US13708761

    申请日:2012-12-07

    Abstract: The present invention relates to the use of VEGF antagonists and alpha5beta1 antagonists for treating cancer and inhibiting angiogenesis and/or vascular permeability, including inhibiting abnormal angiogenesis in diseases. The present invention also relates to use of a VEGFR agonists and alpha5beta1 agonists to promote angiogenesis and vascular permeability. The present invention also relates to new anti-alpha5beta1 antibodies, compositions and kits comprising them and methods of making and using them.

    Abstract translation: 本发明涉及VEGF拮抗剂和α5β1拮抗剂用于治疗癌症并抑制血管生成和/或血管通透性的用途,包括抑制疾病中的异常血管发生。 本发明还涉及VEGFR激动剂和α5β1激动剂促进血管生成和血管通透性的用途。 本发明还涉及新的抗α5β1抗体,包含它们的组合物和试剂盒以及制备和使用它们的方法。

Patent Agency Ranking